Patents by Inventor Marlise Amstutz

Marlise Amstutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIA BASED PROTEIN DELIVERY
    Publication number: 20230382956
    Abstract: The present invention relates to recombinant Gram-negative bacterial strains and its use in a method of treating cancer in a subject.
    Type: Application
    Filed: October 26, 2021
    Publication date: November 30, 2023
    Inventors: Marlise AMSTUTZ, Simon ITTIG, Christoph KASPER, Mathias S. DICK, Falk SAUPE
  • Virulence Attenuated Bacteria Based Protein Delivery
    Publication number: 20230250138
    Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains and its use in a method of treating cancer in a subject.
    Type: Application
    Filed: October 18, 2022
    Publication date: August 10, 2023
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper
  • Bacteria-based protein delivery
    Patent number: 11702663
    Abstract: The present invention relates to recombinant Gram-negative bacterial strains and the use thereof for delivery of repeated domains of a heterologous protein or two or more domains of different heterologous proteins into eukaryotic cells.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: July 18, 2023
    Assignee: Universität Basel
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper
  • Virulence attenuated bacteria based protein delivery
    Patent number: 11518789
    Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains and its use in a method of treating cancer in a subject.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 6, 2022
    Assignee: Universitaet Basel
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper
  • Virulence attenuated bacteria for treatment of malignant solid tumors
    Patent number: 11166987
    Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: November 9, 2021
    Assignee: Universitaet Basel
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper, Guy R. Cornelis
  • VIRULENCE ATTENUATED BACTERIA BASED PROTEIN DELIVERY
    Publication number: 20200123207
    Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains and its use in a method of treating cancer in a subject.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 23, 2020
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper
  • Bacteria-Based Protein Delivery
    Publication number: 20190194670
    Abstract: The present invention relates to recombinant Gram-negative bacterial strains and the use thereof for delivery of repeated domains of a heterologous protein or two or more domains of different heterologous proteins into eukaryotic cells.
    Type: Application
    Filed: November 17, 2016
    Publication date: June 27, 2019
    Inventors: Simon ITTIG, Marlise AMSTUTZ, Christoph KASPER
  • Virulence Attenuated Bacteria For Treatment Of Malignant Solid Tumors
    Publication number: 20190015497
    Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
    Type: Application
    Filed: November 17, 2016
    Publication date: January 17, 2019
    Inventors: Simon Ittig, Marlise Amstutz, Christoph Kasper, Guy R. Cornelis